Literature DB >> 17190826

Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.

Erik R Vandendries1, Justin R Hamilton, Shaun R Coughlin, Bruce Furie, Barbara C Furie.   

Abstract

Thrombin, a central mediator of hemostasis and thrombosis, converts fibrinogen to fibrin and is a potent platelet activator. Activated platelets provide a surface for assembly of the tenase and prothrombinase complexes required for thrombin generation. The role of thrombin-induced platelet activation in platelet accumulation and its interplay with fibrin deposition during thrombus assembly has not been fully defined. We studied these processes during laser-induced thrombus formation by using real-time digital fluorescence microscopy in mice lacking protease-activated receptor-4 (Par4), which is necessary for thrombin responsiveness in mouse platelets. Juxtamural platelet accumulation immediately after laser injury was not different in wild-type and Par4(-/-) mice. However, subsequent growth of platelet thrombi was markedly diminished in Par4(-/-) mice. At the time of maximal thrombus size in wild type, platelet accumulation was more than 10-fold higher in wild type than in Par4(-/-) mice. P-selectin expression, a marker of platelet activation, was reduced and delayed in Par4(-/-) thrombi. In contrast to platelet activation and accumulation, the rate and amount of fibrin deposition, predominantly intramural and juxtamural in this model, were indistinguishable in Par4(-/-) and wild-type mice. These results suggest that platelet activation by thrombin is necessary for normal propagation of a platelet thrombus at a distance from the injured vessel wall and hence for normal thrombus growth. However, platelet activation by thrombin is unnecessary for initial and limited accumulation of platelets at or near the vessel wall, and this limited accumulation of platelets and/or platelet-independent mechanism(s) of thrombin generation are sufficient for normal fibrin deposition in this model.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190826      PMCID: PMC1765451          DOI: 10.1073/pnas.0610188104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Platelet activation and blood coagulation.

Authors:  Johan W M Heemskerk; Edouard M Bevers; Theo Lindhout
Journal:  Thromb Haemost       Date:  2002-08       Impact factor: 5.249

3.  In vivo models of platelet function and thrombosis: study of real-time thrombus formation.

Authors:  Shahrokh Falati; Peter L Gross; Glenn Merrill-Skoloff; Derek Sim; Robert Flaumenhaft; Alessandro Celi; Barbara C Furie; Bruce Furie
Journal:  Methods Mol Biol       Date:  2004

4.  Protection against thrombosis in mice lacking PAR3.

Authors:  Ethan J Weiss; Justin R Hamilton; Katy E Lease; Shaun R Coughlin
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

5.  Role of thrombin signalling in platelets in haemostasis and thrombosis.

Authors:  G R Sambrano; E J Weiss; Y W Zheng; W Huang; S R Coughlin
Journal:  Nature       Date:  2001-09-06       Impact factor: 49.962

Review 6.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

7.  Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi.

Authors:  E D Rosen; S Raymond; A Zollman; F Noria; M Sandoval-Cooper; A Shulman; J L Merz; F J Castellino
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

8.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  Blockade of the thrombin receptor protease-activated receptor-1 with a small-molecule antagonist prevents thrombus formation and vascular occlusion in nonhuman primates.

Authors:  Claudia K Derian; Bruce P Damiano; Michael F Addo; Andrew L Darrow; Michael R D'Andrea; Mark Nedelman; Han-Cheng Zhang; Bruce E Maryanoff; Patricia Andrade-Gordon
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

10.  Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.

Authors:  Shahrokh Falati; Qingde Liu; Peter Gross; Glenn Merrill-Skoloff; Janet Chou; Erik Vandendries; Alessandro Celi; Kevin Croce; Barbara C Furie; Bruce Furie
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  79 in total

1.  Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects.

Authors:  Teddy Kosoglou; Larisa Reyderman; Renger G Tiessen; André A van Vliet; Robert R Fales; Robert Keller; Bo Yang; David L Cutler
Journal:  Eur J Clin Pharmacol       Date:  2011-09-21       Impact factor: 2.953

Review 2.  Imaging coagulation reactions in vivo.

Authors:  Lacramioara Ivanciu; Sriram Krishnaswamy; Rodney M Camire
Journal:  Thromb Res       Date:  2012-03-08       Impact factor: 3.944

3.  Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.

Authors:  Hadil Owaynat; Ivan S Yermolenko; Ramya Turaga; Valeryi K Lishko; Michael R Sheller; Tatiana P Ugarova
Journal:  Thromb Res       Date:  2015-10-09       Impact factor: 3.944

4.  Injury measurements improve interpretation of thrombus formation data in the cremaster arteriole laser-induced injury model of thrombosis.

Authors:  Steven P Grover; Pavan K Bendapudi; Moua Yang; Glenn Merrill-Skoloff; Vijay Govindarajan; Alexander Y Mitrophanov; Robert Flaumenhaft
Journal:  J Thromb Haemost       Date:  2020-10-29       Impact factor: 5.824

Review 5.  Antiplatelet agents in clinical practice and their haemorrhagic risk.

Authors:  Paolo Gresele
Journal:  Blood Transfus       Date:  2013-05-09       Impact factor: 3.443

6.  A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood.

Authors:  Keith B Neeves; Scott L Diamond
Journal:  Lab Chip       Date:  2008-04-03       Impact factor: 6.799

Review 7.  Mouse laser injury models: variations on a theme.

Authors:  Timothy J Stalker
Journal:  Platelets       Date:  2020-04-16       Impact factor: 3.862

Review 8.  Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo.

Authors:  L Ivanciu; T J Stalker
Journal:  J Thromb Haemost       Date:  2015-10-23       Impact factor: 5.824

Review 9.  Regulatory role of thiol isomerases in thrombus formation.

Authors:  Anish Sharda; Bruce Furie
Journal:  Expert Rev Hematol       Date:  2018-03-28       Impact factor: 2.929

10.  Protease-activated receptors in cancer: A systematic review.

Authors:  Na Han; Ketao Jin; Kuifeng He; Jiang Cao; Lisong Teng
Journal:  Oncol Lett       Date:  2011-04-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.